-
The annual European Association for the Study of Diabetes (EASD) conference in Hamburg on 2-6 October brought together global experts to share findings in diabetes research.
-
Clinical trial findings for new survodutide and semaglutide treatments and promising phase 2 retatrutide results.
-
Updates include teplizumab to delay type 1 diabetes onset and early screening for liver disease.
The potential of fasting to help prevent and reverse type 2 diabetes has recently started to gain recognition in the medical community and beyond.
> Read more
Women with diabetes face unique challenges in many aspects of their lives, including in healthcare, the workplace and social interactions. Addressing these obstacles is crucial in creating a more inclusive and supportive environment for them.
> Read more
Diabetes educators play a pivotal role in diabetes education by providing accurate information, promoting self-management strategies, and combating stigma and misinformation.
> Read more
Meet Sofie Schunk, a runner with type 1 diabetes who qualified for the US 2024 Olympic Marathon Trials, as she shares insights on training for a marathon.
> Read more
Sexual dysfunction can affect relationships and treatment outcomes, even impacting social interactions and mental health.
> Read more